Profile data is unavailable for this security.
About the company
Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company focused on the development and commercialization of a pharmaceutical delivery platform. The Company is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The Company's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The Company also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.
- Revenue in AUD (TTM)366.64k
- Net income in AUD-3.94m
- Incorporated2014
- Employees14.00
- LocationMedlab Clinical LtdUnits 5 And 6 11 Lord Street BotanyALEXANDRIA 2019AustraliaAUS
- Phone+61 28188-0311
- Fax+61 29699-3347
- Websitehttps://www.medlab.co/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avecho Biotechnology Ltd | 473.55k | -3.44m | 7.92m | 29.00 | -- | 1.24 | -- | 16.73 | -0.0016 | -0.0016 | 0.0002 | 0.002 | 0.0888 | 2.07 | 0.5132 | -- | -64.45 | -47.08 | -75.73 | -55.25 | -9.25 | 78.67 | -725.70 | -156.43 | 8.19 | -- | 0.0267 | -- | -58.07 | -19.42 | -46.71 | -- | -- | -- |
| Island Pharmaceuticals Ltd | 10.28k | -2.37m | 8.62m | -- | -- | 9.75 | -- | 838.54 | -0.026 | -0.026 | 0.0001 | 0.007 | 0.0038 | -- | 0.0318 | -- | -88.77 | -- | -134.02 | -- | -- | -- | -23,100.68 | -- | -- | -- | 0.4433 | -- | -- | -- | -8.58 | -- | -- | -- |
| Bioxyne Ltd | 8.65m | -14.17m | 10.23m | 16.00 | -- | 3.28 | -- | 1.18 | -0.0074 | -0.0074 | 0.0044 | 0.0015 | 1.83 | 6.12 | 10.50 | -- | -302.23 | -22.07 | -418.10 | -28.50 | 38.30 | 45.13 | -165.04 | -39.69 | 1.50 | -- | 0.00 | -- | 1,013.05 | 20.97 | -292.69 | -- | -19.86 | -- |
| BTC Health Ltd | 16.03k | -8.26m | 12.64m | 1.00 | -- | 2.33 | 7.66 | 788.57 | -0.0305 | -0.0305 | 0.00005 | 0.0167 | 0.0017 | -- | 0.031 | -- | -89.67 | -23.15 | -91.36 | -24.64 | -- | -- | -51,522.02 | -2,498.18 | -- | -0.0787 | 0.00 | -- | -86.04 | -26.76 | -1,665.01 | -- | -- | -- |
| Adalta Ltd | 3.56m | -5.04m | 14.29m | -- | -- | 5.21 | -- | 4.01 | -0.0129 | -0.0129 | 0.0092 | 0.0046 | 0.5491 | -- | 4.72 | -- | -77.76 | -67.77 | -195.09 | -103.16 | -- | -- | -141.60 | -160.72 | -- | -57.86 | 0.4533 | -- | 28.18 | 11.17 | 19.96 | -- | -7.47 | -- |
| Patrys Ltd | 1.70m | -5.12m | 14.40m | 15.00 | -- | 2.87 | -- | 8.50 | -0.0025 | -0.0025 | 0.0008 | 0.0024 | 0.1978 | -- | 0.5828 | -- | -59.77 | -43.96 | -68.99 | -47.06 | -- | -- | -302.26 | -230.44 | -- | -- | 0.00 | -- | -14.45 | 40.52 | -4.15 | -- | -- | -- |
| Rhythm Biosciences Ltd | 157.67k | -8.63m | 14.42m | -- | -- | 10.54 | -- | 91.45 | -0.0386 | -0.0386 | 0.0007 | 0.0055 | 0.0263 | -- | 1.81 | -- | -144.00 | -106.11 | -169.71 | -125.51 | -1,899.74 | -1,210.71 | -5,473.20 | -6,642.26 | 2.04 | -- | 0.0304 | -- | 814.18 | 28.77 | 6.55 | -- | -20.43 | -- |
| Tissue Repair Ltd | 457.52k | -3.28m | 14.51m | -- | -- | 0.8426 | -- | 31.72 | -0.0542 | -0.0542 | 0.0076 | 0.2848 | 0.0209 | -- | 7.95 | -- | -14.96 | -- | -15.46 | -- | 98.19 | -- | -716.30 | -- | 25.84 | -- | 0.00 | -- | -- | -- | 38.95 | -- | -- | -- |
| Algorae Pharmaceuticals Ltd | 84.10k | -2.25m | 15.19m | -- | -- | 4.19 | -- | 180.58 | -0.0015 | -0.0015 | 0.00006 | 0.0022 | 0.0245 | -- | 1.79 | -- | -65.51 | -46.12 | -70.91 | -53.52 | -- | -- | -2,678.04 | -591.05 | -- | -136.75 | 0.00 | -- | 1,132.26 | -44.06 | -7.68 | -- | -- | -- |
| Medlab Clinical Ltd | 366.64k | -3.94m | 15.31m | 14.00 | -- | -- | -- | 41.77 | -1.73 | -1.73 | 0.1606 | -0.3068 | 0.1069 | -- | 5.82 | -- | -103.72 | -55.07 | -240.52 | -69.75 | 84.77 | 52.86 | -970.74 | -335.43 | -- | -342.19 | -- | -- | -28.90 | -29.83 | 18.55 | -- | -30.00 | -- |
| Amplia Therapeutics Ltd | 4.44m | -4.50m | 16.73m | 1.00 | -- | 1.07 | -- | 3.77 | -0.0226 | -0.0226 | 0.0222 | 0.0572 | 0.2647 | -- | 2.05 | -- | -26.86 | -25.13 | -32.90 | -27.42 | -- | -- | -101.48 | -206.74 | -- | -- | 0.122 | -- | 286.42 | 144.81 | 27.86 | -- | -6.91 | -- |
| Chimeric Therapeutics Ltd | 0.00 | -11.31m | 17.52m | -- | -- | 1.05 | -- | -- | -0.027 | -0.027 | 0.00 | 0.0191 | 0.00 | -- | -- | -- | -45.96 | -- | -69.36 | -- | -- | -- | -- | -- | -- | -10.01 | 0.1596 | -- | -- | -- | -60.40 | -- | -- | -- |
| Noxopharm Ltd | 3.90m | -12.13m | 20.46m | 1.00k | -- | 3.11 | -- | 5.24 | -0.0415 | -0.0415 | 0.0134 | 0.0225 | 0.2684 | -- | 1.64 | 3,901.84 | -83.43 | -50.96 | -94.78 | -62.98 | -- | -- | -310.82 | -191.70 | -- | -1.47 | 0.00 | -- | 11.32 | 44.02 | 19.34 | -- | -- | -- |
| BPH Energy Ltd | 345.67k | 894.65k | 20.66m | 2.00k | 18.37 | 0.8882 | -- | 59.76 | 0.001 | 0.001 | 0.0004 | 0.0203 | 0.0177 | -- | 5.97 | -- | 4.58 | -6.89 | 4.78 | -7.72 | 56.39 | -- | 258.50 | -357.76 | -- | -- | 0.0043 | -- | 96.54 | 5.21 | 179.13 | -- | -- | -- |
| Alterity Therapeutics Ltd | 123.46k | -12.28m | 21.28m | 11.00 | -- | 0.6361 | -- | 172.37 | -0.005 | -0.005 | 0.00005 | 0.0063 | 0.0044 | -- | 1.52 | 11,223.64 | -44.20 | -53.02 | -53.57 | -61.96 | -- | -- | -9,947.97 | -40,995.62 | -- | -- | 0.0143 | -- | 557.60 | -39.40 | -7.47 | -- | -34.88 | -- |
| Tryptamine Therapeutics Ltd | 1.21m | -4.32m | 21.78m | -- | -- | 3.24 | -- | 18.04 | -0.0162 | -0.0162 | 0.0039 | 0.0062 | 0.2368 | -- | -- | -- | -84.69 | -- | -120.26 | -- | -- | -- | -357.70 | -- | -- | -21.62 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Data as of Feb 22 2023. Currency figures normalised to Medlab Clinical Ltd's reporting currency: Australian Dollar AUD
